NEW YORK, NY / ACCESSWIRE / February 27, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and micro-cap public companies is issuing a comprehensive report with no obligation on OWC Pharmaceutical Research Corp (OWCP). OWC Pharmaceutical, through its wholly owned subsidiary, One World Cannabis Ltd, conducts medical research and clinical trials to develop cannabis-based pharmaceuticals and treatments for conditions including multiple myeloma, psoriasis, fibromyalgia, PTSD, and migraines. It is also developing unique delivery systems for effective delivery and dosage of medical cannabis. All its research is conducted at leading Israeli hospitals and scientific institutions, and led by internationally renowned investigators.
The state of Israel has been supportive of cannabis study and scientific research since the 1960’s in renowned academic and research hospitals. The Medical Cannabis Unit under the Health Minister Office has